App-Quantinova.ai

Pathological features and lessons learned from screen detected ductal carcinoma in situ (DCIS) - Results from 11 337 cases in the UK Sloane project

Abeer M Shaaban - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Ultra-deep multigene profiling of matched primary and metastatic hormone receptor positive breast cancer patients relapsed after adjuvant endocrine treatment reveals novel aberrations in the estrogen receptor pathway

Gabriele Zoppoli - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Viable circulating ensembles of tumor associated cells persist in patients with no radiologically detectable disease after treatment in breast cancer

Ajay Srinivasan - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Indocyanine green (ICG) fluorescence mapping for sentinel lymph node (SLN) localization in early breast cancer

Dorin Dumitru - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Factors affecting the number of sentinel lymph nodes removed in the treatment and staging of breast cancer?

J Michael Dixon - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Generation of nomograms to predict non-sentinel node metastasis and poorer patient response to neoadjuvant chemotherapy in primary breast cancer: A 10-year study

Sam Jenkins - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Whole-exome and RNA-sequencing analyses of acinic cell carcinomas of the breast

Francisco Beca - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

A systematic review of the receptor status and genomic landscape of breast cancer brain metastases

Alexander James Morgan - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Brain metastasis

N/A

Multi-parameter FACS sorting identifies higher mutational burden in aromatase inhibitor resistant subclones in estrogen positive breast cancer at diagnosis

Eugene F Schuster - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Collagenase

Heterogeneity of DCIS does not appear to be a biomarker for development of subsequent invasive cancer

Anargyros Megalios - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Genomic analysis of paired DCIS and subsequent recurrence to assess clonal relatedness in screen detected DCIS

Vandna Shah - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

TP53

Breast cancer subtype classification using NanoString and RNAseq technologies

Andrea Rocca - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

UltraSEEK breast cancer panel for low frequency mutation detection in breast cancer brain metastasis

Athina Giannoudis - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Brain metastasis

N/A

The genomic landscape of male breast cancers using the oncomine comprehensive assay for actionable mutations

Jane Bayani - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Baseline and pharmacodynamic changes of circulating exosomal microRNAs predict early versus late progression to palbociclib plus endocrine therapy in patients with metastatic breast cancer. A sub-analysis of the PARSIFAL-1 trial

David Casadevall - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Fulvestrant

Dosimetric comparison of breast and pan nodal radiotherapy techniques to estimate the risk of developing a second primary cancer in the upper inner quadrant of the contralateral breast

Sarah Settatree - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Partial breast irradiation, simultaneous integrated boost and regional nodal irradiation: A UK private provider approach to maximising patient access to advanced breast radiotherapy

Penny Kechagioglou - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

The oncological safety of autologous fat grafting after breast conserving surgery for breast cancer: A systematic review, meta- analysis and meta regression analysis of observational studies

Salim Tayeh - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Oncoplastic breast conserving surgery (OBCS): A meta-analysis of real-world data

Sebastian Kosasih - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

An evaluation of patient reported outcomes following oncoplastic breast conserving surgery with a crescent modification of the chest wall perforated flap utilizing Breast Q

Amtul R Carmichael - San Antonio Breast Cancer Symposium (SABCS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

N/A

Filters

45280 Abstracts